资讯

MPR16 小时
June 2025 Recap: Drug Pipeline Updates
The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on ...
infomeddnews3 天
June 25, 2025 - Page 9 Of 9 - Medical Device News Magazine
Riliprubart Earns Orphan Drug Designation in the US for Antibody-mediated Rejection in Solid Organ Transplantation This designation reflects Sanofi’s commitment to addressing a critical unmet need in ...
Sanofi’s (NASDAQ:SNY) Riliprubart Granted Orphan Frug Designation in Japan
Sanofi (NASDAQ:SNY) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 30, Sanofi (NASDAQ:SNY) announced that ...
FDA Grants Orphan Drug Designation To Sanofi’s (SNY) Riliprubart
Sanofi (NASDAQ:SNY) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 25, Sanofi (NASDAQ:SNY) ...
10 Best Dip Stocks to Buy According to Billionaires
Sanofi (NASDAQ: SNY) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 25, Sanofi (NASDAQ:SNY) ...
Sanofi’s Riliprubart Gains Orphan Drug Status in US and Japan
In June 2025, Sanofi announced that its investigational drug riliprubart received orphan drug designation from the US FDA for treating antibody-mediated rejection in solid organ transplantation, ...